Anxiety, psychosis and substance use: prevalence, correlates and recognition in an outpatient mental health setting

Prevalence of depressive symptoms and associated factors among people who inject drugs in China

“…Such results were consistent with other studies that found positive associations between severity of substance dependence and poor mental health (Marini et al, 2013;Wyman et al, 2011). MMT can effectively reduce the severity of drug dependence among PWID (Shi et al, 2007).…”

“…Over half of the adults suffering from mental disorders in China had never utilized any mental health services ; there is a shortage of mental health services and interventions targeting PWID in China (Gu et al, 2010). Severity of substance dependence is another risk factor of poor mental health (Marini et al, 2013;Wyman et al, 2011) and HIVrelated risk behaviors among PWID in China (Gu et al, 2008a). With availability of methadone maintenance treatment (MMT), it is possible to reduce severity of drug dependence among PWID (Shi et al, 2007).…”

Identifying co-occurring substance use disorders in community mental health centres. Tailored approaches are needed

“…Secondly, we found that the patients with co-occurring substance use disorders had more severe morbidity as measured with the HoNOS on five out of eleven parameters. Higher morbidity among patients with co-occurring mental and substance use disorders has been found in several studies (231,233,256,259). One study, targeting patients in community mental health centres with measures comparable to our study, found that patients with schizophrenia in inpatient and outpatient clinics with co-occurring substance use disorders had higher sum-scores on the HoNOS than patients without this comorbidity (260).…”

“…The main finding from our first paper was that the different approaches we used to estimate the prevalence of substance use disorders in our population of patients in community mental health centres gave estimates between 10 and 12 %, which is on a level with the 12-month prevalence observed in the general population (29,(49)(50)(51)(52)(53)(54). Given the high comorbidity of mental and substance use disorders (29,49,55,57,(226)(227)(228), one would expect the prevalence to be higher in this clinical population (60,61,(229)(230)(231)(232)(233)(234)(235). By combining the different measures in our study, the prevalence of substance use disorders increased to 17 %, which is still somewhat low, but more comparable to what would be expected in a psychiatric outpatient population (229,(231)(232)(233).…”

“…Given the high comorbidity of mental and substance use disorders (29,49,55,57,(226)(227)(228), one would expect the prevalence to be higher in this clinical population (60,61,(229)(230)(231)(232)(233)(234)(235). By combining the different measures in our study, the prevalence of substance use disorders increased to 17 %, which is still somewhat low, but more comparable to what would be expected in a psychiatric outpatient population (229,(231)(232)(233).…”